Look Up > Drugs > Iodoquinol
Iodoquinol
Pronunciation
U.S. Brand Names
Generic Available
Canadian Brand Names
Synonyms
Pharmacological Index
Use
Pregnancy Risk Factor
Contraindications
Warnings/Precautions
Adverse Reactions
Overdosage/Toxicology
Drug Interactions
Mechanism of Action
Pharmacodynamics/Kinetics
Usual Dosage
Dietary Considerations
Monitoring Parameters
Test Interactions
Mental Health: Effects on Mental Status
Mental Health: Effects on Psychiatric Treatment
Dental Health: Local Anesthetic/Vasoconstrictor Precautions
Dental Health: Effects on Dental Treatment
Patient Information
Nursing Implications
Dosage Forms
References

Pronunciation
(eye oh doe KWIN ole)

U.S. Brand Names
Yodoxin®

Generic Available

No


Canadian Brand Names
Diodoquin®

Synonyms
Diiodohydroxyquin

Pharmacological Index

Amebicide


Use

Treatment of acute and chronic intestinal amebiasis; asymptomatic cyst passers; Blastocystis hominis infections; ineffective for amebic hepatitis or hepatic abscess


Pregnancy Risk Factor

C


Contraindications

Known hypersensitivity to iodine or iodoquinol; hepatic damage; pre-existing optic neuropathy


Warnings/Precautions

Optic neuritis, optic atrophy, and peripheral neuropathy have occurred following prolonged use; avoid long-term therapy


Adverse Reactions

>10%: Gastrointestinal: Diarrhea, nausea, vomiting, stomach pain

1% to 10%:

Central nervous system: Fever, chills, agitation, retrograde amnesia, headache

Dermatologic: Rash, urticaria

Endocrine & metabolic: Thyroid gland enlargement

Neuromuscular & skeletal: Peripheral neuropathy, weakness

Ocular: Optic neuritis, optic atrophy, visual impairment

Miscellaneous: Itching of rectal area


Overdosage/Toxicology

Chronic overdose can result in vomiting, diarrhea, abdominal pain, metallic taste, paresthesias, paraplegia, and loss of vision; can lead to destruction of the long fibers of the spinal cord and optic nerve

Acute overdose: Delirium, stupor, coma, amnesia

Following GI decontamination, treatment is symptomatic


Drug Interactions

No data reported


Mechanism of Action

Contact amebicide that works in the lumen of the intestine by an unknown mechanism


Pharmacodynamics/Kinetics

Absorption: Oral: Poor and irregular

Metabolism: In the liver

Elimination: High percentage of the dose excreted in feces


Usual Dosage

Oral:

Adults: 650 mg 3 times/day after meals for 20 days; not to exceed 1.95 g/day


Dietary Considerations

Should be administered after meals


Monitoring Parameters

Ophthalmologic exam


Test Interactions

May increase protein-bound serum iodine concentrations reflecting a decrease in 131I uptake; false-positive ferric chloride test for phenylketonuria


Mental Health: Effects on Mental Status

May cause agitation or amnesia


Mental Health: Effects on Psychiatric Treatment

None reported


Dental Health: Local Anesthetic/Vasoconstrictor Precautions

No information available to require special precautions


Dental Health: Effects on Dental Treatment

No effects or complications reported


Patient Information

Take as directed; complete full course of therapy. Maintain adequate hydration (2-3 L/day of fluids unless instructed to restrict fluid intake) and nutrition. If GI upset occurs, small frequent meals, frequent mouth care, sucking lozenges, or chewing gum may help. Report unresolved or severe nausea or vomiting, skin rash, fever, or fatigue. Pregnancy/breast-feeding precautions: Inform prescriber if you are or intend to be pregnant. Consult prescriber if breast-feeding.


Nursing Implications

Tablets may be crushed and mixed with applesauce or chocolate syrup


Dosage Forms

Powder: 25 g

Tablet: 210 mg, 650 mg


References

"Drugs for Parasitic Infections," Med Lett Drugs Ther, 1993, 35(911):111-22.


Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved